# Treatment of Chronic Bacterial Prostatitis

> **NCT02130713** · PHASE4 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 210 (actual)

## Conditions studied

- Chronic Bacterial Prostatitis

## Interventions

- **DRUG:** Third generation fluoroquinolone
- **DIETARY_SUPPLEMENT:** Nutritional supplement + third generation fluoroquinolone

## Key facts

- **NCT ID:** NCT02130713
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130713, "Treatment of Chronic Bacterial Prostatitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02130713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*